Zoledronic acid concurrent with either high- or reduced-dose palliative radiotherapy in the management of the breast cancer patients with bone metastases: a phase IV randomized clinical study
Titel:
Zoledronic acid concurrent with either high- or reduced-dose palliative radiotherapy in the management of the breast cancer patients with bone metastases: a phase IV randomized clinical study
Auteur:
Atahan, Lale Yıldız, Ferah Cengiz, Mustafa Kaplan, Bunyamin Özkan, Metin Yazici, Gozde Gündoğ, Mete Haydaroğlu, Ayfer Korcum, Aylin F. Şengöz, Meriç Dinçer, Maktav Akmansu, Müge Engin, Kayıhan Hayran, Mutlu